BioNTech SE (BNTX) Intangibles (2018 - 2025)
BioNTech SE (BNTX) posted Intangibles of $1.9 billion for Q4 2025, up 15.06% on a QoQ basis from $1.6 billion in Q3 2025, and up 121.34% year-over-year from $844.6 million in Q4 2024.
BioNTech SE (BNTX) has 8 years of Intangibles data on file, last reported at $1.9 billion in Q4 2025.
- In Q4 2025, Intangibles rose 121.34% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (up 121.34% YoY), while the FY2025 annual figure was $1.8 billion, up 114.83% from the prior year.
- Intangibles grew to $1.9 billion in Q4 2025, from $1.6 billion in the prior quarter.
- Across five years, Intangibles topped out at $1.9 billion in Q4 2025 and bottomed at -$78.5 million in Q4 2022.
- A 5-year average of $710.9 million and a median of $635.2 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles tumbled 218.66% — and 2023, when it soared 1202.72%.
- Year by year, Intangibles stood at $66.1 million in 2021, then tumbled by 218.66% to -$78.5 million in 2022, then soared by 1202.72% to $865.2 million in 2023, then decreased by 2.37% to $844.6 million in 2024, then jumped by 121.34% to $1.9 billion in 2025.
- The last three Intangibles figures came in at $1.9 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.7 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 1.87 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.87 Bn |
| Sep 30, 2025 | 1.62 Bn |
| Jun 30, 2025 | 1.68 Bn |
| Mar 31, 2025 | 1.59 Bn |
| Dec 31, 2024 | 844.62 Mn |
| Sep 30, 2024 | 959.73 Mn |
| Jun 30, 2024 | 928.60 Mn |
| Mar 31, 2024 | 892.66 Mn |
| Dec 31, 2023 | 865.16 Mn |
| Sep 30, 2023 | 724.46 Mn |
| Jun 30, 2023 | 545.99 Mn |
| Mar 31, 2023 | 406.37 Mn |
| Dec 31, 2022 | -78.46 Mn |
| Sep 30, 2022 | 228.07 Mn |
| Jun 30, 2022 | 236.25 Mn |
| Mar 31, 2022 | 242.42 Mn |
| Dec 31, 2021 | 66.12 Mn |
| Sep 30, 2021 | 192.11 Mn |
| Jun 30, 2021 | 197.62 Mn |
| Mar 31, 2021 | 199.27 Mn |
| Dec 31, 2020 | 7.15 Mn |
| Sep 30, 2020 | 197.09 Mn |
| Jun 30, 2020 | 201.88 Mn |
| Mar 31, 2020 | 103.70 Mn |
| Dec 31, 2019 | 2.66 Mn |
| Sep 30, 2019 | 105.13 Mn |
| Dec 31, 2018 | 100.49 Mn |